Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis

2.

Sung

H

,

Ferlay

J

,

Siegel

RL

,

Laversanne

M

,

Soerjomataram

I

,

Jemal

A

, et al.

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

.

CA Cancer J Clin

.

2021

;

71

(

3

):

209

–

49

.

3.

Torre

LA

,

Bray

F

,

Siegel

RL

,

Ferlay

J

,

Lortet-Tieulent

J

,

Jemal

A

.

Global cancer statistics, 2012

.

CA Cancer J Clin

.

2015

;

65

(

2

):

87

–

108

.

4.

Torre

LA

,

Islami

F

,

Siegel

RL

,

Ward

EM

,

Jemal

A

.

Global cancer in women: burden and trends

.

Cancer Epidemiol Biomarkers Prev

.

2017

;

26

(

4

):

444

–

57

.

5.

Bray

F

,

Ferlay

J

,

Soerjomataram

I

,

Siegel

RL

,

Torre

LA

,

Jemal

A

.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

.

CA Cancer J Clin

.

2018

;

68

(

6

):

394

–

424

.

6.

Argilés

JM

,

Busquets

S

,

Stemmler

B

,

López-Soriano

FJ

.

Cancer cachexia: understanding the molecular basis

.

Nat Rev Cancer

.

2014

;

14

(

11

):

754

–

62

.

7.

Islami

F

,

Torre

LA

,

Drope

JM

,

Ward

EM

,

Jemal

A

.

Global cancer in women: cancer control priorities

.

Cancer Epidemiol Biomarkers Prev

.

2017

;

26

(

4

):

458

–

70

.

8.

Fearon

K

,

Strasser

F

,

Anker

SD

,

Bosaeus

I

,

Bruera

E

,

Fainsinger

RL

, et al.

Definition and classification of cancer cachexia: an international consensus

.

Lancet Oncol

.

2011

;

12

(

5

):

489

–

95

.

9.

Visser

LL

,

Groen

EJ

,

van Leeuwen

FE

,

Lips

EH

,

Schmidt

MK

,

Wesseling

J

.

Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses

.

Cancer Epidemiol Biomarkers Prev

.

2019

;

28

(

5

):

835

–

45

.

10.

Jeon

YW

,

Park

HS

,

Ko

Y

,

Sung

YS

,

Shim

BY

,

Suh

YJ

, et al.

Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy

.

BC Res Treat

.

2021

;

189

(

3

):

759

–

68

.

11.

Liu

X

,

Zhang

E

,

Wang

S

,

Shen

Y

,

Xi

K

,

Fang

Q

.

Association of body composition with clinical outcome in Chinese women diagnosed with breast cancer

.

Front Oncol

.

2022

;

12

:

957527

.

12.

Buckinx

F

,

Aubertin-Leheudre

M

.

Sarcopenia in menopausal women: current perspectives

.

Int J Womens Health

.

2022

;

14

:

805

–

19

.

13.

Song

H-N

,

Kim

JY

,

Kim

JM

,

Kang

KM

,

Choi

HS

,

Jeong

JH

, et al.

Sarcopenia using pectoralis muscle area and lymphocyte-to-monocyte ratio (LMR) are independent prognostic factors in patients for nonmetastatic breast cancer

.

Medicine

.

2022

;

101

(

49

):

e32229

.

14.

Thormann

M

,

Heitmann

F

,

March

C

,

Pech

M

,

Hass

P

,

Surov

A

, et al.

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases

.

J Contemp Brachytherapy

.

2022

;

14

(

4

):

364

–

9

.

15.

Pepersack

T

.

For an operational definition of cachexia

.

Lancet Oncol

.

2011

;

12

(

5

):

423

–

4

.

16.

Rensing

L

,

Ockenga

J

.

[Muscle wasting (sarcopenia/cachexia) and malnutrition: new insights into development and therapy]

.

Dtsch Med Wochenschr

.

2010

;

135

(

33

):

1605

–

11

.

17.

Yuan

S

,

Larsson

SC

.

Epidemiology of sarcopenia: prevalence, risk factors, and consequences

.

Metabolism

.

2023

;

144

:

155533

.

18.

Jiang

F-L

,

Tang

S

,

Eom

S-H

,

Lee

J-Y

,

Chae

JH

,

Kim

C-H

.

Distribution of bioelectrical impedance vector analysis and phase angle in Korean elderly and sarcopenia

.

Sensors

.

2023

;

23

(

16

):

7090

.

19.

Wu

J

,

Lin

S

,

Guan

J

,

Wu

X

,

Ding

M

,

Shen

S

.

Prediction of the sarcopenia in peritoneal dialysis using simple clinical information: a machine learning-based model

.

Semin Dial

.

2023

;

36

(

5

):

390

–

8

.

20.

Tan

T-W

,

Tan

H-L

,

Hsu

M-F

,

Huang

H-L

,

Chung

Y-C

.

Effect of non-pharmacological interventions on the prevention of sarcopenia in menopausal women: a systematic review and meta-analysis of randomized controlled trials

.

BMC Womens Health

.

2023

;

23

(

1

):

606

.

21.

Jeejeebhoy

KN

.

Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features

.

Curr Opin Clin Nutr Metab Care

.

2012

;

15

(

3

):

213

–

9

.

22.

Aleixo

GFP

,

Williams

GR

,

Nyrop

KA

,

Muss

HB

,

Shachar

SS

.

Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review

.

BC Res Treat

.

2019

;

177

(

3

):

569

–

79

.

23.

Zhang

X-M

,

Dou

Q-L

,

Zeng

Y

,

Yang

Y

,

Cheng

ASK

,

Zhang

W-W

.

Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review

.

BMC Cancer

.

2020

;

20

(

1

):

172

.

24.

Huang

W-J

,

Zhang

M-L

,

Wang

W

,

Jia

Q-C

,

Yuan

J-R

,

Zhang

X

, et al.

Preoperative pectoralis muscle index predicts distant metastasis-free survival in breast cancer patients

.

Front Oncol

.

2022

;

12

:

854137

.

25.

Miao

S

,

Jia

H

,

Cheng

K

,

Hu

X

,

Li

J

,

Huang

W

, et al.

Deep learning radiomics under multimodality explore association between muscle/fat and metastasis and survival in breast cancer patients

.

Brief Bioinform

.

2022

;

23

(

6

):

bbac432

.

26.

Saraf

A

,

Tahir

I

,

Hu

B

,

Dietrich

A-SW

,

Tonnesen

PE

,

Sharp

GC

, et al.

Association of sarcopenia with toxicity-related discontinuation of adjuvant endocrine therapy in women with early-stage hormone receptor-positive BC

.

Int J Radiat Oncol Biol Phys

.

2023

;

S0360-3016

(

23

):

07679

–

4

.

27.

Yao

H

,

Dohzono

S

,

Sasaoka

R

,

Takamatsu

K

,

Nakamura

H

.

Prognostic value of psoas major muscle density in patients with breast cancer metastases to bone: a retrospective single-center cohort study

.

Jpn J Clin Oncol

.

2022

;

52

(

1

):

8

–

13

.

28.

Page

MJ

,

McKenzie

JE

,

Bossuyt

PM

,

Boutron

I

,

Hoffmann

TC

,

Mulrow

CD

, et al.

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

.

Syst Rev

.

2021

;

10

(

1

):

89

.

29.

Ouzzani

M

,

Hammady

H

,

Fedorowicz

Z

,

Elmagarmid

A

.

Rayyan: a web and mobile app for systematic reviews

.

Syst Rev

.

2016

;

5

(

1

):

210

.

30.

Borenstein

M

.

Comprehensive meta‐analysis software

.

2022

; p.

535

–

48

.

31.

Higgins

JPT

,

Thompson

SG

.

Quantifying heterogeneity in a meta-analysis

.

Stat Med

.

2002

;

21

(

11

):

1539

–

58

.

32.

Duval

S

,

Tweedie

R

.

A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis

.

J Am Stat Assoc

.

2000

;

95

(

449

):

89

–

98

.

33.

Caan

BJ

,

Cespedes Feliciano

EM

,

Prado

CM

,

Alexeeff

S

,

Kroenke

CH

,

Bradshaw

P

, et al.

Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer

.

JAMA Oncol

.

2018

;

4

(

6

):

798

–

804

.

34.

Deluche

E

,

Leobon

S

,

Desport

JC

,

Venat-Bouvet

L

,

Usseglio

J

,

Tubiana-Mathieu

N

.

Impact of body composition on outcome in patients with early breast cancer

.

Support Care Cancer

.

2018

;

26

(

3

):

861

–

8

.

35.

Hua

X

,

Deng

J-P

,

Long

Z-Q

,

Zhang

W-W

,

Huang

X

,

Wen

W

, et al.

Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy

.

Curr Probl Cancer

.

2020

;

44

(

2

):

100513

.

36.

Huh

J

,

Park

B

,

Lee

H

,

An

Y-S

,

Jung

Y

,

Kim

JY

, et al.

Prognostic value of skeletal muscle depletion measured on computed tomography for overall survival in patients with non-metastatic breast cancer

.

J BC

.

2020

;

23

(

1

):

80

–

92

.

37.

Palleschi

M

,

Prochowski Iamurri

A

,

Scarpi

E

,

Mariotti

M

,

Maltoni

R

,

Mannozzi

F

, et al.

Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab

.

Sci Rep

.

2022

;

12

(

1

):

3385

.

38.

Rier

HN

,

Jager

A

,

Sleijfer

S

,

van Rosmalen

J

,

Kock

MCJM

,

Levin

M-D

.

Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy

.

Breast Edinb Scotl

.

2017

;

31

:

9

–

15

.

39.

Shachar

SS

,

Deal

AM

,

Weinberg

M

,

Nyrop

KA

,

Williams

GR

,

Nishijima

TF

, et al.

Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy

.

Clin Cancer Res

.

2017

;

23

(

3

):

658

–

65

.

40.

Sheean

P

,

Gomez-Perez

S

,

Joyce

C

,

O’Connor

P

,

Bojko

M

,

Smith

A

, et al.

Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer

.

BC Res Treat

.

2021

;

190

(

1

):

121

–

32

.

41.

Song

EJ

,

Lee

CW

,

Jung

S-Y

,

Kim

BN

,

Lee

KS

,

Lee

S

, et al.

Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer

.

BC Res Treat

.

2018

;

172

(

2

):

425

–

36

.

42.

Tang

R

,

Deng

J-P

,

Zhang

L

,

Zhang

W-W

,

Sun

J-Y

,

Chi

F

, et al.

Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy

.

BMC Cancer

.

2022

;

22

(

1

):

234

.

43.

Villaseñor

A

,

Ballard-Barbash

R

,

Baumgartner

K

,

Baumgartner

R

,

Bernstein

L

,

McTiernan

A

, et al.

Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study

.

J Cancer Surviv

.

2012

;

6

(

4

):

398

–

406

.

44.

Satija

A

,

Ahmed

SM

,

Gupta

R

,

Ahmed

A

,

Rana

SPS

,

Singh

SP

, et al.

Breast cancer pain management: a review of current and novel therapies

.

Indian J Med Res

.

2014

;

139

(

2

):

216

–

25

.

45.

Silver

JK

,

Raj

VS

,

Fu

JB

,

Wisotzky

EM

,

Smith

SR

,

Kirch

RA

.

Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services

.

Support Care Cancer

.

2015

;

23

(

12

):

3633

–

43

.

46.

Cella

D

,

Fallowfield

LJ

.

Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy

.

BC Res Treat

.

2008

;

107

(

2

):

167

–

80

.

47.

Irvin

W

,

Muss

HB

,

Mayer

DK

.

Symptom management in metastatic breast cancer

.

Oncologist

.

2011

;

16

(

9

):

1203

–

14

.

48.

Cardoso

F

,

Senkus

E

,

Costa

A

,

Papadopoulos

E

,

Aapro

M

,

André

F

, et al.

4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)†

.

Ann Oncol

.

2018

;

29

(

8

):

1634

–

57

.

49.

Lawrence

R

,

Watters

M

,

Davies

CR

,

Pantel

K

,

Lu

Y-J

.

Circulating tumour cells for early detection of clinically relevant cancer

.

Nat Rev Clin Oncol

.

2023

;

20

(

7

):

487

–

500

.

50.

Steeg

PS

.

Targeting metastasis

.

Nat Rev Cancer

.

2016

;

16

(

4

):

201

–

18

.

51.

Caetano Dos Santos

FL

,

Michalek

IM

,

Wojciechowska

U

,

Didkowska

J

.

Changes in the survival of patients with breast cancer: Poland, 2000-2019

.

BC Res Treat

.

2023

;

197

(

3

):

623

–

31

.

52.

Plichta

JK

,

Rushing

CN

,

Lewis

HC

,

Rooney

MM

,

Blazer

DG

,

Thomas

SM

, et al.

Implications of missing data on reported breast cancer mortality

.

BC Res Treat

.

2023

;

197

(

1

):

177

–

87

.

53.

Campbell

KL

,

Winters-Stone

KM

,

Wiskemann

J

,

May

AM

,

Schwartz

AL

,

Courneya

KS

, et al.

Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable

.

Med Sci Sports Exerc

.

2019

;

51

(

11

):

2375

–

90

.

54.

Kim

J

,

Choi

WJ

,

Jeong

SH

.

The effects of physical activity on breast cancer survivors after diagnosis

.

J Cancer Prev

.

2013

;

18

(

3

):

193

–

200

.

55.

Joaquim

A

,

Leão

I

,

Antunes

P

,

Capela

A

,

Viamonte

S

,

Alves

AJ

, et al.

Impact of physical exercise programs in breast cancer survivors on health-related quality of life, physical fitness, and body composition: evidence from systematic reviews and meta-analyses

.

Front Oncol

.

2022

;

12

:

955505

.

56.

Loprinzi

PD

,

Cardinal

BJ

.

Effects of physical activity on common side effects of breast cancer treatment

.

BC

.

2012

;

19

(

1

):

4

–

10

.

57.

Soares Falcetta

F

,

de Araújo Vianna Träsel

H

,

de Almeida

FK

,

Rangel Ribeiro Falcetta

M

,

Falavigna

M

,

Dornelles Rosa

D

.

Effects of physical exercise after treatment of early breast cancer: systematic review and meta-analysis

.

BC Res Treat

.

2018

;

170

(

3

):

455

–

76

.

58.

Delrieu

L

,

Jacquet

E

,

Segura-Ferlay

C

,

Blanc

E

,

Febvey-Combes

O

,

Friedenreich

C

, et al.

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

.

Sci Rep

.

2020

;

10

(

1

):

10757

.

59.

Limon-Miro

AT

,

Valencia

ME

,

Lopez-Teros

V

,

Alemán-Mateo

H

,

Méndez-Estrada

RO

,

Pacheco-Moreno

BI

, et al.

An individualized food-based nutrition intervention reduces visceral and total body fat while preserving skeletal muscle mass in breast cancer patients under antineoplastic treatment

.

Clin Nutr

.

2021

;

40

(

6

):

4394

–

403

.